-
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
Monday, March 17, 2025 - 1:39pm | 460Read More...Pliant Therapeutics, Inc. (NASDAQ:PLRX) released on Monday data from the first three of five potential cohorts of its ongoing Phase 1 dose escalation trial of PLN-101095, in combination with Merck & Co Inc.’s (NYSE:MRK) Keytruda (pembrolizumab), in patients with immune...
-
Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment
Monday, March 17, 2025 - 12:21pm | 438Read More...Scholar Rock Holding Corp. (NASDAQ:SRRK) said on Sunday the company will present new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. The Phase 3 SAPPHIRE trial evaluated the efficacy and safety...
-
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
Thursday, March 13, 2025 - 2:52pm | 713Read More...H.C. Wainwright & Co. initiated coverage on Thursday for Perspective Therapeutics, Inc. (NASDAQ:CATX), a clinical-stage biotechnology company advancing “targeted radiotherapy agents” for cancer treatment. Analyst Robert Burns initiated a Buy rating and a price target of $10. The...
-
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
Tuesday, January 21, 2025 - 7:27pm | 650Read More...According to the latest data from the Centers for Disease Control and Prevention, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus. The virus was confirmed on Friday at a commercial poultry production facility in Georgia, the...
-
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
Thursday, January 16, 2025 - 3:10pm | 564Read More...In a court filing on Monday, the Department of Health and Human Services (HHS) challenged Vertex Pharmaceuticals Inc (NASDAQ:VRTX), defending its stance that the company’s proposed fertility services program would breach anti-kickback laws. The program is tied to Vertex’s gene-editing...
-
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Wednesday, December 18, 2024 - 3:29pm | 460Read More...Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC) and Crohn’s disease (CD). In the RELIEVE UCCD study, 36.2% (low-dose) and 47.8% (high-dose) of patients with...
-
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
Wednesday, August 21, 2024 - 5:05pm | 457Read More...GeoVax Labs Inc (NASDAQ:GOVX) shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Michigan’s Wayne County confirmed its first case of mpox since 2022. What Happened: According to a Fox Detroit report, the Wayne County...
-
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Monday, August 19, 2024 - 12:08pm | 776Read More...The U.S. Food and Drug Administration (FDA) may approve updated COVID-19 vaccines this week to combat recent strains as the country endures its most significant summer outbreak in two years. The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc. (NASDAQ:MRNA) and Pfizer Inc...
-
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
Friday, August 16, 2024 - 10:43am | 787Read More...Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) submitted clinical data on Thursday to the European Medicines Agency (EMA) to support the extension of the Imvanex (MVA-BN) smallpox and mpox vaccine indication to include adolescents 12 to 17 years of age. Jynneos is known internationally as...
-
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Wednesday, August 14, 2024 - 4:04pm | 409Read More...GeoVax Labs inc. (NASDAQ:GOVX) and SIGA Technologies Inc. (NASDAQ:SIGA) shares are surging Wednesday amid Mpox Emergency Declaration. Here’s what you need to know. What Happened: The surge comes in response to reports that the World Health Organization (WHO) Director General has declared Mpox...
-
Rocket Mortgage Classic Announces Inaugural 'Bow Tie Day' To Honor Founder Dan Gilbert's Son
Monday, June 26, 2023 - 7:47pm | 428Read More...Last month, Nick Gilbert, the son of Rocket Mortgage founder and Cleveland Cavaliers owner Dan Gilbert and wife Jennifer Gilbert, passed away tragically due to complications from neurofibromatosis at the age of 26. The Rocket Mortgage Classic announced Thursday, June 29, is “...
-
Bill Gates Warns This Deadly Virus Is Spreading: 'It Remains A Threat To All Of Us'
Sunday, July 24, 2022 - 1:14pm | 472Read More...Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates, also one of the biggest donors to the World Health Organization, has been battling to eradicate certain diseases spreading across the world. Gates and his philanthropic initiative, the Bill & Melinda Gates Foundation, have worked...
-
BofA Securities Highlights PepGen Clinical Trials: Why It Matters
Tuesday, May 31, 2022 - 1:34pm | 233Read More...PepGen Inc’s (NASDAQ: PEPG) lead asset, PGN-EDO51 for Duchenne muscular dystrophy (DMD), is in phase 1 clinical trials in healthy volunteers with data expected by the end of the year, according to BofA Securities. The PepGen Analyst: Tazeen Ahmad initiated coverage of PepGen with a Buy rating...














